Business Wire

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
Morningstar

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics

First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying blood-brain barrier drug transport and neuroinflammation. Emulate, Inc., the leading ...
Business Wire

Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to reduce reliance on ...
STAT

Improving inflammatory disease drug development with organ-on-a-chip technology

Inflammatory diseases pose a substantial global health burden, causing three out of every five deaths worldwide. However, due to the limitations of the conventional, simplistic 2D models, researchers ...
Reuters

Seres, Emulate collaborate to advance Emulate's intestine-chip platform

* Seres and Emulate will work to advance Emulate's intestine-chip platform, a living-tissue-based system that models human intestine ...
sciencex

NIH funds next phase of Tissue Chip for Drug Screening program

The National Institutes of Health will award funds to support the next phase of its Tissue Chip for Drug Screening program to improve ways of predicting drug safety and effectiveness. Researchers will ...